Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-27T02:51:50.187Z Has data issue: false hasContentIssue false
  • English
  • Français

Changes in valvular regurgitation in mid-term follow-up of children with first attack acute rheumatic fever: first evaluation after the updated Jones criteria

Published online by Cambridge University Press:  10 January 2020

Muhlike Güler Open the ORCID record for Muhlike Güler [Opens in a new window] ,
Fuat Laloğlu  and
Naci Ceviz
Muhlike Güler*
Affiliation:
Department of Pediatric Cardiology, Ataturk University Medical Faculty, Erzurum, Turkey
Fuat Laloğlu
Affiliation:
Department of Pediatric Cardiology, Ataturk University Medical Faculty, Erzurum, Turkey
Naci Ceviz
Affiliation:
Department of Pediatric Cardiology, Ataturk University Medical Faculty, Erzurum, Turkey
*
Author for correspondence: M. Güler, Department of Pediatric Cardiology, Ataturk University Medical Faculty, Erzurum, Turkey. Phone: 0442 0344 78 85; Fax: 0442 344 78 67; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Aim:

In present study, we aimed to evaluate the changes in valvular regurgitations in mid-term follow-up of children with first attack acute rheumatic fever diagnosed after updated Jones criteria.

Materials and methods:

The medical records of the children diagnosed with acute rheumatic fever between June 2015 and November 2018 were evaluated retrospectively. When compared to the findings during diagnosis, the changes in the degree of valvular regurgitation in the last visit were coded as same, regressed, or disappeared.

Results:

A total of 50 children were diagnosed with the first attack of acute rheumatic fever between the noted dates. Nine patients (18%) could be diagnosed depending on the new criteria. Eight patients did not have carditis, and 35 patients (49 valves) could be followed for a median follow-up period of 11.7 ± 3.3 months. In our study, the valvar lesions continued in 82% of patients with clinical carditis at the end of the first year and the degree of valvular regurgitation decreased in 39% of them. Despite this, in a significantly higher (p = 0.031) ratio of patients with silent carditis (41%), valvar lesions disappeared in the same follow-up period. In 18.4% of the involved valves, regurgitation regressed to physiological level.

Conclusion:

Updated Jones criteria make it possible to diagnose a significant number of patients, and the ratio of complete recovery among patients with silent carditis is significantly higher. Also, it can be speculated that the normal children in whom a physiological mitral regurgitation is detected should be followed in terms of rheumatic heart disease.

Keywords

Acute rheumatic feverchildrenupdated Jones criteria
Type
Original Article
Information
Cardiology in the Young , Volume 30 , Issue 3 , March 2020 , pp. 369 - 371
Copyright
© Cambridge University Press 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Carapetis, R, Mc Donald, M, Wilson, N.A acute rheumatic fever. Lancet 2005; 366: 155–166.CrossRefGoogle ScholarPubMed
Gewitz, MH, Baltimore, RS, Tani, LY, et al.American Heart Association Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease of the Council on Cardiovascular Disease in the Young. Revision of the Jones criteria for the diagnosis of the rheumatic fever in the era of Doppler echocardiography: a scientific statement of the American Heart Association. Circulation 2015; 131: 1806–1818.CrossRefGoogle Scholar
Dajani, AS, Ayooub, E, Bierman, FZ, et al.Special Writing Group of the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease of the Council on Cardiovascular Disease in the Young the American Heart Association. Guidelines for the diagnosis of rheumatic fever. Jones criteria, 1992 update. JAMA 1992; 268: 2069–2073.CrossRefGoogle Scholar
Orün, UA, Ceylan, O, Bilici, M, et al.Acute rheumatic fever in the Central Anatolia Region of Turkey: a 30-year experience in a single center. Eur J Pediatr 2012; 171: 361–368.CrossRefGoogle ScholarPubMed
Licciardi, F, Scaioli, G, Mulatero, R, et alEpidemiologic impact of the new guidelines for the diagnosis of acute rheumatic fever. J Pediatr 2018; 198: 25–28.CrossRefGoogle Scholar
Giannoulia-Karantana, A, Anagnostopoulos, G, Kostaridou, S, et al.Childhood acute rheumatic fever in Greece: experience of the past 18 years. Acta Paediatr 2001; 90: 809–912.CrossRefGoogle ScholarPubMed
Chockalingam, A, Gnanavelu, G, Elangovan, S, et al.Current profile of acute rheumatic fever and valvulitis in southern India. J Heart Valve Dis 2003; 12: 573–576.Google ScholarPubMed
Pirinççioğlu, AG, Alyan, Ö, Kanğın, Met al.Akut romatizmal ateşli çocuklarda klinik ve laboratuvar bulguların geriye dönük olarak incelenmesi: reaktivasyon ve koruyucu tedaviye uyumunun araştırılması. Arch Turk Soc Cardiol 2012; 40: 427–435.Google Scholar
Özkutlu, S, Hallioglu, O, Ayabakan, C.Evaluation of subclinical valvar disease in patients with rheumatic fever. Cardiol Young 2003; 13: 495–499.CrossRefGoogle ScholarPubMed
Figueroa, FE, Fernández, MS, Valdés, P, et al.Prospective comparison of clinical and echocardiographic diagnosis of rheumatic carditis: long term follow up of patients with subclinical disease. Heart 2001; 85: 407–410.CrossRefGoogle ScholarPubMed
Lanna, CC, Tonelli, E, Barros, MV, et al.Subclinical rheumatic valvitis: a long-term follow-up. Cardiol Young 2003; 13: 431–438.CrossRefGoogle ScholarPubMed
World Health Organization. Rheumatic Fever and Rheumatic Heart Disease: Report of a WHO Expert Consultation, Geneva, 29 October–1 November 2001. World Health Organization Geneva, Switzerland, 2001. WHO Technical Report Series 923. Accessed May 18, 2011, from http://www.who.int/cardiovascular_diseases/resources/en/cvd_trs923.pdfGoogle Scholar